Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511433
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2007-08-02
Brief Title:
Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSPEE 292003COMPLETEDP05723
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Randomized Open-Label Comparative Trial to Evaluate the Effects on Ovarian Function of a Monophasic Combined Oral Contraceptive COC Containing 25 mg Nomegestrol Acetate NOMAC and 15 mg Estradiol E2 Compared to a Monophasic COC Containing 3 mg Drospirenone DRSP and 30 ug Ethinyl Estradiol EE
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to evaluate the effects of the nomegestrol acetate-estradiol NOMAC-E2 combined oral contraceptive COC on ovarian function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Organon protocol 292003 | None | None | None |